Loading...
Header Logo
Keywords
Last Name
KP Region

Cynthia I Campbell PhD, MPH

TitleResearch Scientist II|
InstitutionKaiser Permanente Northern California
DepartmentDivision of Research
ORCID ORCID Icon0000-0003-1019-5852 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of California, San DiegoB.A.06/1989Psychology
    University of California, Los AngelesM.P.H.06/1997Health Services
    University of Michigan, Ann ArborPh.D.03/2003Health Services, Organization, and Policy
    University of California, San FranciscoPostdoctoral Fellowship2006Substance Abuse and Health Services

    Collapse Overview 
    Collapse overview
    Dr. Cynthia Campbell is a research scientist at the Division of Research, Kaiser Permanente Northern California, conducting research on the treatment of substance use and mental health problems. She is also an Adjunct Associate Professor in the Department of Psychiatry, University of California, San Francisco. Her interests include access to treatment, chronic pain and substance use, prescription opioid use and misuse, adolescent behavioral health, benefit design and cost sharing, and organizational factors and policy related to these areas. She is currently the principal investigator of a NIDA-funded study examining the impact of the ACA on addiction and HIV services, a NIDA-funded study examining substance use service intensity for buprenorphine patients, and a PCORI-funded study of a patient activation intervention in primary care for chronic pain patients starting long-term prescription opioid use. Her work also includes the assessment of attention deficit hyperactivity disorder (ADHD) in children. She received her doctorate in Public Health at the University of Michigan, and conducted her postdoctoral work at UCSF in a NIDA-funded fellowship on Substance Abuse and Health Services.

    Collapse Research 
    Collapse research activities and funding
    R21AA016326     (CAMPBELL, CYNTHIA I)Aug 1, 2007 - Jul 31, 2010
    NIH/NIAAA
    Patients with Alcohol Problems and Chronic Pain: Use of Alcohol and Pain Services
    Role: Principal Investigator

    R01AA018142     (CAMPBELL, CYNTHIA I)May 20, 2010 - Apr 30, 2013
    NIH/NIAAA
    Alcohol Trajectories and Service Use in Young Adults: Nine Years Post Treatment
    Role: Principal Investigator

    R01DA030438     (CAMPBELL, CYNTHIA I)Sep 15, 2011 - Aug 31, 2014
    NIH/NIDA
    High Deductible Health Plans: Substance Abuse Service Use and Cost Trajectories
    Role: Principal Investigator

    R21DA035645     (SATRE, DEREK D.)May 1, 2013 - Apr 30, 2014
    NIH/NIDA
    The Impact of Health Care Reform on Addiction and HIV Services
    Role: Co-Principal Investigator

    R33DA035645     (SATRE, DEREK D.)May 1, 2013 - Apr 30, 2018
    NIH/NIDA
    The Impact of Health Care Reform on Addiction and HIV Services
    Role: Principal Investigator

    R01DA036603     (CAMPBELL, CYNTHIA I)Sep 15, 2014 - Aug 31, 2018
    NIH/NIDA
    Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence
    Role: Principal Investigator

    UG1DA040314     (CAMPBELL, CYNTHIA I)Sep 1, 2015 - May 31, 2020
    NIH/NIDA
    Integrating Addiction Research in Health Systems: The Addiction Research Network
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Young-Wolff KC, Adams SR, Klebaner D, Adams AS, Campbell CI, Satre DD, Prochaska JJ. Evaluating the Impact of Eliminating Copayments for Tobacco Cessation Pharmacotherapy. Med Care. 2018 Nov; 56(11):912-918. PMID: 30234768.
      View in: PubMed
    2. Samuels EA, D'Onofrio G, Huntley K, Levin S, Schuur JD, Bart G, Hawk K, Tai B, Campbell CI, Venkatesh AK. A Quality Framework for Emergency Department Treatment of Opioid Use Disorder. Ann Emerg Med. 2018 Oct 11. PMID: 30318376.
      View in: PubMed
    3. Campbell CI, Parthasarathy S, Altschuler A, Young-Wolff KC, Satre DD. Characteristics of patients with substance use disorder before and after the Affordable Care Act. Drug Alcohol Depend. 2018 Dec 01; 193:124-130. PMID: 30366189.
      View in: PubMed
    4. Bahorik AL, Sterling SA, Campbell CI, Weisner C, Ramo D, Satre DD. Medical and non-medical marijuana use in depression: Longitudinal associations with suicidal ideation, everyday functioning, and psychiatry service utilization. J Affect Disord. 2018 Dec 01; 241:8-14. PMID: 30086434.
      View in: PubMed
    5. Yarborough BJH, Chi FW, Green CA, Hinman A, Mertens J, Beck A, Horberg M, Weisner C, Campbell CI. Patient and System Characteristics Associated with Performance on the HEDIS Measures of Alcohol and Other Drug Treatment Initiation and Engagement. J Addict Med. 2018 Jul/Aug; 12(4):278-286. PMID: 29557802.
      View in: PubMed
    6. Campbell CI, Bahorik AL, VanVeldhuisen P, Weisner C, Rubinstein AL, Ray GT. Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health system. Prev Med. 2018 May; 110:31-37. PMID: 29410132.
      View in: PubMed
    7. Ramo DE, Bahorik AL, Delucchi KL, Campbell CI, Satre DD. Alcohol and Drug Use, Pain and Psychiatric Symptoms among Adults Seeking Outpatient Psychiatric Treatment: Latent Class Patterns and Relationship to Health Status. J Psychoactive Drugs. 2018 Jan-Mar; 50(1):43-53. PMID: 29199899.
      View in: PubMed
    8. Bahorik AL, Campbell CI, Sterling SA, Leibowitz A, Travis A, Weisner CM, Satre DD. Adverse impact of marijuana use on clinical outcomes among psychiatry patients with depression and alcohol use disorder. Psychiatry Res. 2018 01; 259:316-322. PMID: 29100135.
      View in: PubMed
    9. Bahorik AL, Satre DD, Kline-Simon AH, Weisner CM, Young-Wolff KC, Campbell CI. Alcohol, marijuana, and opioid use disorders: 5-Year patterns and characteristics of emergency department encounters. Subst Abus. 2018 01 02; 39(1):59-68. PMID: 28723312.
      View in: PubMed
    10. Young-Wolff KC, Klebaner D, Weisner C, Von Korff M, Campbell CI. Smoking Status and Opioid-related Problems and Concerns Among Men and Women on Chronic Opioid Therapy. Clin J Pain. 2017 Aug; 33(8):730-737. PMID: 27898458.
      View in: PubMed
    11. Bahorik AL, Satre DD, Kline-Simon AH, Weisner CM, Campbell CI. Serious mental illness and medical comorbidities: Findings from an integrated health care system. J Psychosom Res. 2017 09; 100:35-45. PMID: 28789791.
      View in: PubMed
    12. Campbell CI, Bahorik AL, Kline-Simon AH, Satre DD. The role of marijuana use disorder in predicting emergency department and inpatient encounters: A retrospective cohort study. Drug Alcohol Depend. 2017 09 01; 178:170-175. PMID: 28651153.
      View in: PubMed
    13. Young-Wolff KC, Klebaner D, Campbell CI, Weisner C, Satre DD, Adams AS. Association of the Affordable Care Act With Smoking and Tobacco Treatment Utilization Among Adults Newly Enrolled in Health Care. Med Care. 2017 05; 55(5):535-541. PMID: 28288073.
      View in: PubMed
    14. Ray GT, Bahorik AL, VanVeldhuisen PC, Weisner CM, Rubinstein AL, Campbell CI. Prescription opioid registry protocol in an integrated health system. Am J Manag Care. 2017 May 01; 23(5):e146-e155. PMID: 28810131.
      View in: PubMed
    15. Campbell CI, Parthasarathy S, Young-Wolff KC, Satre DD. Buprenorphine Treatment and Patient Use of Health Services after the Affordable Care Act in an Integrated Health Care System. J Psychoactive Drugs. 2017 Apr-Jun; 49(2):160-168. PMID: 28426332.
      View in: PubMed
    16. Ray GT, Weisner CM, Taillac CJ, Campbell CI. The high price of depression: Family members' health conditions and health care costs. Gen Hosp Psychiatry. 2017 05; 46:79-87. PMID: 28622822.
      View in: PubMed
    17. Campbell CI, Kline-Simon AH, Von Korff M, Saunders KW, Weisner C. Alcohol and Drug Use and Aberrant Drug-Related Behavior Among Patients on Chronic Opioid Therapy. Subst Use Misuse. 2017 08 24; 52(10):1283-1291. PMID: 28346056.
      View in: PubMed
    18. Green CA, Perrin NA, Janoff SL, Campbell CI, Chilcoat HD, Coplan PM. Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records. Pharmacoepidemiol Drug Saf. 2017 May; 26(5):509-517. PMID: 28074520.
      View in: PubMed
    19. Lui CK, Sterling SA, Chi FW, Lu Y, Campbell CI. Socioeconomic differences in adolescent substance abuse treatment participation and long-term outcomes. Addict Behav. 2017 05; 68:45-51. PMID: 28088743.
      View in: PubMed
    20. Bahorik AL, Satre DD, Kline-Simon AH, Weisner CM, Campbell CI. Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System. J Addict Med. 2017 Jan/Feb; 11(1):3-9. PMID: 27610582.
      View in: PubMed
    21. Satre DD, Altschuler A, Parthasarathy S, Silverberg MJ, Volberding P, Campbell CI. Implementation and Operational Research: Affordable Care Act Implementation in a California Health Care System Leads to Growth in HIV-Positive Patient Enrollment and Changes in Patient Characteristics. J Acquir Immune Defic Syndr. 2016 Dec 15; 73(5):e76-e82. PMID: 27749602.
      View in: PubMed
    22. Campbell CI, Sterling S, Chi FW, Kline-Simon AH. Marijuana use and service utilization among adolescents 7 years post substance use treatment. Drug Alcohol Depend. 2016 11 01; 168:1-7. PMID: 27606492.
      View in: PubMed
    23. Janoff SL, Perrin NA, Coplan PM, Chilcoat HD, Campbell CI, Green CA. Protocol: changes in rates of opioid overdose and poisoning events in an integrated health system following the introduction of a formulation of OxyContin® with abuse-deterrent properties. BMC Pharmacol Toxicol. 2016 05 14; 17(1):21. PMID: 27177423; PMCID: PMC4867981.
    24. Satre DD, Parthasarathy S, Altschuler A, Silverberg MJ, Storholm E, Campbell CI. Demographic, Insurance, and Health Characteristics of Newly Enrolled HIV-Positive Patients After Implementation of the Affordable Care Act in California. Am J Public Health. 2016 07; 106(7):1211-3. PMID: 27077361.
      View in: PubMed
    25. Parthasarathy S, Campbell CI. High-Deductible Health Plans: Implications for Substance Use Treatment. Health Serv Res. 2016 10; 51(5):1939-59. PMID: 26840191.
      View in: PubMed
    26. Mertens JR, Chi FW, Weisner CM, Satre DD, Ross TB, Allen S, Pating D, Campbell CI, Lu YW, Sterling SA. Physician versus non-physician delivery of alcohol screening, brief intervention and referral to treatment in adult primary care: the ADVISe cluster randomized controlled implementation trial. Addict Sci Clin Pract. 2015 Nov 19; 10:26. PMID: 26585638; PMCID: PMC4653951.
    27. LeResche L, Saunders K, Dublin S, Thielke S, Merrill JO, Shortreed SM, Campbell C, Von Korff MR. Sex and Age Differences in Global Pain Status Among Patients Using Opioids Long Term for Chronic Noncancer Pain. J Womens Health (Larchmt). 2015 Aug; 24(8):629-35. PMID: 26153668; PMCID: PMC4545568.
    28. Thielke SM, Turner JA, Shortreed SM, Saunders K, Leresche L, Campbell CI, Weisner CC, Korff MV. Do patient-perceived pros and cons of opioids predict sustained higher-dose use? Clin J Pain. 2014 Feb; 30(2):93-101. PMID: 23535150; PMCID: PMC3805783.
    29. Chi FW, Sterling S, Campbell CI, Weisner C. 12-step participation and outcomes over 7 years among adolescent substance use patients with and without psychiatric comorbidity. Subst Abus. 2013; 34(1):33-42. PMID: 23327502; PMCID: PMC3558833.
    30. Merrill JO, Von Korff M, Banta-Green CJ, Sullivan MD, Saunders KW, Campbell CI, Weisner C. Prescribed opioid difficulties, depression and opioid dose among chronic opioid therapy patients. Gen Hosp Psychiatry. 2012 Nov-Dec; 34(6):581-7. PMID: 22959422; PMCID: PMC3665511.
    31. Howe CQ, Sullivan MD, Saunders KW, Merrill JO, Banta-Green CJ, Weisner C, Campbell CI, Von Korff M. Depression and ambivalence toward chronic opioid therapy for chronic noncancer pain. Clin J Pain. 2012 Sep; 28(7):561-6. PMID: 22699127; PMCID: PMC3414634.
    32. Grattan A, Sullivan MD, Saunders KW, Campbell CI, Von Korff MR. Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse. Ann Fam Med. 2012 Jul-Aug; 10(4):304-11. PMID: 22778118; PMCID: PMC3392289.
    33. Mundt MP, Parthasarathy S, Chi FW, Sterling S, Campbell CI. 12-Step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment. Drug Alcohol Depend. 2012 Nov 01; 126(1-2):124-30. PMID: 22633367; PMCID: PMC3430743.
    34. Ramirez R, Hinman A, Sterling S, Weisner C, Campbell C. Peer influences on adolescent alcohol and other drug use outcomes. J Nurs Scholarsh. 2012 Mar; 44(1):36-44. PMID: 22339982; PMCID: PMC3287367.
    35. Chi FW, Campbell CI, Sterling S, Weisner C. Twelve-Step attendance trajectories over 7 years among adolescents entering substance use treatment in an integrated health plan. Addiction. 2012 May; 107(5):933-42. PMID: 22151625; PMCID: PMC3311783.
    36. Saunders KW, Von Korff M, Campbell CI, Banta-Green CJ, Sullivan MD, Merrill JO, Weisner C. Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors. J Pain. 2012 Mar; 13(3):266-75. PMID: 22285611; PMCID: PMC3294025.
    37. Valkanoff TA, Kline-Simon AH, Sterling S, Campbell C, Von Korff M. Functional disability among chronic pain patients receiving long-term opioid treatment. J Soc Work Disabil Rehabil. 2012; 11(2):128-42. PMID: 22630601; PMCID: PMC3718418.
    38. Silverberg MJ, Ray GT, Saunders K, Rutter CM, Campbell CI, Merrill JO, Sullivan MD, Banta-Green CJ, Von Korff M, Weisner C. Prescription long-term opioid use in HIV-infected patients. Clin J Pain. 2012 Jan; 28(1):39-46. PMID: 21677568; PMCID: PMC3175344.
    39. Von Korff M, Merrill JO, Rutter CM, Sullivan M, Campbell CI, Weisner C. Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy. Pain. 2011 Jun; 152(6):1256-62. PMID: 21296498; PMCID: PMC3098951.
    40. Campbell CI, Weisner C, Leresche L, Ray GT, Saunders K, Sullivan MD, Banta-Green CJ, Merrill JO, Silverberg MJ, Boudreau D, Satre DD, Von Korff M. Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health. 2010 Dec; 100(12):2541-7. PMID: 20724688; PMCID: PMC2978198.
    41. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Von Korff M. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010 Jan 19; 152(2):85-92. PMID: 20083827.
      View in: PubMed
    42. Satre DD, Campbell CI, Gordon NS, Weisner C. Ethnic disparities in accessing treatment for depression and substance use disorders in an integrated health plan. Int J Psychiatry Med. 2010; 40(1):57-76. PMID: 20565045; PMCID: PMC2922921.
    43. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, Campbell CI, Merrill JO, Silverberg MJ, Banta-Green C, Weisner C. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009 Dec; 18(12):1166-75. PMID: 19718704; PMCID: PMC3280087.
    44. Braden JB, Sullivan MD, Ray GT, Saunders K, Merrill J, Silverberg MJ, Rutter CM, Weisner C, Banta-Green C, Campbell C, Von Korff M. Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry. 2009 Nov-Dec; 31(6):564-70. PMID: 19892215; PMCID: PMC2774904.
    45. Weisner CM, Campbell CI, Ray GT, Saunders K, Merrill JO, Banta-Green C, Sullivan MD, Silverberg MJ, Mertens JR, Boudreau D, Von Korff M. Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders. Pain. 2009 Oct; 145(3):287-93. PMID: 19581051; PMCID: PMC2929845.
    46. Sterling S, Chi F, Campbell C, Weisner C. Three-year chemical dependency and mental health treatment outcomes among adolescents: the role of continuing care. Alcohol Clin Exp Res. 2009 Aug; 33(8):1417-29. PMID: 19413644; PMCID: PMC2923091.
    47. Chi FW, Kaskutas LA, Sterling S, Campbell CI, Weisner C. Twelve-Step affiliation and 3-year substance use outcomes among adolescents: social support and religious service attendance as potential mediators. Addiction. 2009 Jun; 104(6):927-39. PMID: 19344442; PMCID: PMC2722376.
    48. Campbell CI, Alexander JA, Lemak CH. Organizational determinants of outpatient substance abuse treatment duration in women. J Subst Abuse Treat. 2009 Jul; 37(1):64-72. PMID: 19038526; PMCID: PMC2935286.
    49. Campbell CI, Chi F, Sterling S, Kohn C, Weisner C. Self-initiated tobacco cessation and substance use outcomes among adolescents entering substance use treatment in a managed care organization. Addict Behav. 2009 Feb; 34(2):171-9. PMID: 19010600; PMCID: PMC2700774.
    50. Von Korff M, Korff MV, Saunders K, Thomas Ray G, Boudreau D, Campbell C, Merrill J, Sullivan MD, Rutter CM, Silverberg MJ, Banta-Green C, Weisner C. De facto long-term opioid therapy for noncancer pain. Clin J Pain. 2008 Jul-Aug; 24(6):521-7. PMID: 18574361; PMCID: PMC3286630.
    51. Campbell CI, Wells R, Alexander JA, Jiang L, Nahra TA, Lemak CH. Tailoring of outpatient substance abuse treatment to women, 1995-2005. Med Care. 2007 Aug; 45(8):775-80. PMID: 17667312.
      View in: PubMed
    52. Alexander JA, Nahra TA, Lemak CH, Pollack H, Campbell CI. Tailored treatment in the outpatient substance abuse treatment sector: 1995-2005. J Subst Abuse Treat. 2008 Apr; 34(3):282-92. PMID: 17600653.
      View in: PubMed
    53. Wells R, Lemak CH, Alexander JA, Nahra TA, Ye Y, Campbell CI. Do licensing and accreditation matter in outpatient substance abuse treatment programs? J Subst Abuse Treat. 2007 Jul; 33(1):43-50. PMID: 17588488.
      View in: PubMed
    54. Campbell CI, Weisner C, Sterling S. Adolescents entering chemical dependency treatment in private managed care: ethnic differences in treatment initiation and retention. J Adolesc Health. 2006 Apr; 38(4):343-50. PMID: 16549294.
      View in: PubMed
    55. Campbell CI, Alexander JA. Availability of services for women in outpatient substance abuse treatment: 1995-2000. J Behav Health Serv Res. 2006 Jan; 33(1):1-19. PMID: 16636905.
      View in: PubMed
    56. Campbell CI, Alexander JA. Health services for women in outpatient substance abuse treatment. Health Serv Res. 2005 Jun; 40(3):781-810. PMID: 15960691; PMCID: PMC1361168.
    57. Alexander JA, Lemak CH, Campbell CI. Changes in managed care activity in outpatient substance abuse treatment organizations, 1995-2000. J Behav Health Serv Res. 2003 Oct-Dec; 30(4):369-81. PMID: 14593661.
      View in: PubMed
    58. Lemak CH, Alexander JA, Campbell C. Administrative burden and its implications for outpatient substance abuse treatment organizations. Psychiatr Serv. 2003 May; 54(5):705-11. PMID: 12719502.
      View in: PubMed
    59. Campbell CI, Alexander JA. Culturally competent treatment practices and ancillary service use in outpatient substance abuse treatment. J Subst Abuse Treat. 2002 Apr; 22(3):109-19. PMID: 12039613.
      View in: PubMed
    Campbell's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    © 2018 Kaiser Permanente

    KP Researcher Profiles is funded by Kaiser Permanente Research.